Valuation: 4DMedical Limited

Market Cap 129.48Cr 87Cr 79Cr 73Cr 66Cr 124.57Cr 8.12TCr 885.18Cr 349.9Cr 4.38TCr 326.08Cr 319.25Cr 14TCr P/E 2027 *
-32.9x
P/E 2028 * -67.9x
Enterprise Value 105.82Cr 71Cr 65Cr 60Cr 54Cr 101.81Cr 6.64TCr 723.42Cr 285.96Cr 3.58TCr 266.49Cr 260.91Cr 11TCr EV / Sales 2027 *
53.7x
EV / Sales 2028 * 21.2x
Free-Float
84.09%
Yield 2027 *
-
Yield 2028 * -
1 day+5.12%
1 week-2.16%
Current month-7.38%
1 month-41.60%
3 months-40.37%
6 months-38.08%
Current year-42.49%
1 week 2.02
Extreme 2.02
2.33
1 month 2.02
Extreme 2.02
3.92
Current year 2.02
Extreme 2.02
7.55
1 year 1.4
Extreme 1.4
7.55
3 years 0.22
Extreme 0.225
7.55
5 years 0.22
Extreme 0.225
7.55
10 years 0.22
Extreme 0.225
7.55
Manager TitleAgeSince
Chief Executive Officer - 01/12/2012
Director of Finance/CFO - 28/10/2026
Chief Tech/Sci/R&D Officer - 01/04/2023
Director TitleAgeSince
Director/Board Member - 01/12/2012
Director/Board Member - 01/10/2017
Chairman - 28/10/2026
Date Insider Type Main position Quantity % Market Cap. Importance
18/06/26 Buy

Chief Financial Officer

13,054 0.0022%
04/03/26 Exercice

Director

2,13,464 0.0373%
04/03/26 Exercice

Director

2,13,464 0.0373%
Change 5-day change 1-year change 3-year change Capi.($)
+5.12%-2.16%+57.49%+218.31% 87Cr
+0.87%-3.48%+20.26%+48.52% 26TCr
+1.24%-2.86%+1.36%+10.01% 16TCr
-2.23%-6.36%-23.01%+37.89% 15TCr
+1.42%-3.30%-56.02%-19.69% 6.33TCr
-0.19%-0.55%+25.21%+57.29% 6.05TCr
+0.26%+0.53%+6.43%-11.94% 5.35TCr
+2.97%+0.21%+23.28%+56.72% 5TCr
-3.89%-9.05%+1.27%+57.02% 4.49TCr
+3.63%-1.02%+23.76%+77.98% 4.58TCr
Average +0.92%-3.98%+8.00%+53.21% 9TCr
Weighted average by Cap. +0.38%-3.96%+3.11%+34.38%

Financials

2027 *2028 *
Net sales 1.97Cr 1.32Cr 1.21Cr 1.11Cr 1.01Cr 1.89Cr 123.51Cr 13Cr 5.32Cr 67Cr 4.96Cr 4.85Cr 210.51Cr 5.11Cr 3.43Cr 3.13Cr 2.89Cr 2.61Cr 4.92Cr 320.56Cr 35Cr 14Cr 173.03Cr 13Cr 13Cr 546.37Cr
Net income -4.08Cr -2.74Cr -2.5Cr -2.31Cr -2.08Cr -3.93Cr -255.93Cr -28Cr -11Cr -138.14Cr -10Cr -10Cr -436.21Cr -1.93Cr -1.3Cr -1.18Cr -1.09Cr -98.78L -1.86Cr -121.3Cr -13Cr -5.23Cr -65Cr -4.87Cr -4.77Cr -206.74Cr
Net Debt -24Cr -16Cr -14Cr -13Cr -12Cr -23Cr -1.48TCr -161.75Cr -64Cr -801.12Cr -60Cr -58Cr -2.53TCr -21Cr -14Cr -13Cr -12Cr -11Cr -20Cr -1.33TCr -144.97Cr -57Cr -718.01Cr -53Cr -52Cr -2.27TCr
Projected Income Statement - Annual - 4DMedical Limited
Logo 4DMedical Limited
4DMedical Limited is a medical technology company that creates and deploys software-based cardiothoracic imaging technology integrating both algorithms and artificial intelligence. The Company's software platform delivers quantitative insights from routine clinical imaging to help clinicians assess lung function and cardiopulmonary disease. It provides thoracic imaging that enhances physician diagnoses and management of respiratory conditions. Its products include CT:VQ-Non-Contrast Ventilation-Perfusion, CAC-Coronary Artery Calcification, CT LVAS-Lung Ventilation Analysis, IQ-UIP-Early IPF Detection, LDAf-Functional Lung Density Analysis, LDAi-Lung Density Analysis – Inspiration, LTA-Lung Texture Analysis, PHA-Pulmonary Hypertension Assessment, XV LVAS-Lung Ventilation Analysis, and Companion Imaging. The CT:VQ is a non-contrast post-processing technology that transforms routine, chest computed tomographies (CTs) into quantitative, lobar ventilation (V) and perfusion (Q) maps.
Employees
181
Date Price Change Volume
19/26/19 A$2.260 +5.12% 36,82,341
18/26/18 A$2.150 +0.94% 31,98,173
17/26/17 A$2.130 -2.74% 66,51,734
16/26/16 A$2.190 -4.78% 34,82,634
13/26/13 A$2.300 -0.43% 34,76,890
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
MarketScreener Ratings - 4DMedical Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
2.150AUD
Average target price
4.167AUD
Spread / Average Target
+93.80%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - 4DMedical Limited